Does aprepitant change chemo levels? new study investigates
NCT ID NCT03514381
First seen Apr 28, 2026 · Last updated Jun 09, 2026 · Updated 11 times
Summary
This study looked at how the anti-nausea medication aprepitant changes the levels of the chemotherapy drug ifosfamide in the blood of people with soft tissue sarcoma. Fifty-nine patients receiving standard chemotherapy (doxorubicin and ifosfamide) were followed for two treatment cycles. The goal was to measure ifosfamide levels with and without aprepitant to understand any drug interaction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Bergonie
Bordeaux, 33076, France
-
Institut Regional Du Cancer de Montpellier (Icm)
Montpellier, 34298, France
-
Institut Universitaire Du Cancer de Toulouse - Oncopole
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.